Illustratively, BPC 157 may interfere with NO-system activities (Sikiric et al., 2014) and counteract harmful events, arising from either NO-blockade (L-NAME-application) or L-arginine (NOS-substrate-application) (Sikiric et al., 2014)
Monitoring during a BPC-157 protocol should include regular assessment of the target outcome, whether that is a functional performance metric, a validated symptom score for gut health, or imaging of a healing musculoskeletal injury
Injections are given intramuscularly and should only be administered by trained clinicians to ensure safety and effectiveness
Inject: choose a clean site, avoid scars or inflamed areas, and inject the peptide solution
You can ask your doctor or pharmacist to go through the procedure with you beforehand
For people who want a broader view of peptide options, the peptide therapy page shows how Livv groups peptides by goals